1-3 of 3
Michael McDermott
Close
Save search
Sort by
Journal Articles

Cost-Effectiveness Model of Recombinant FVIII Versus Emicizumab Treatment of Patients With Severe Hemophilia A Without Inhibitors

Free
Shawn X. Sun, Yanyu Wu, Michael McDermott, Marjolijn van Keep
Journal: Blood
Blood (2019) 134 (Supplement_1): 2102.
https://doi.org/10.1182/blood-2019-124421
Published: 2019
Journal Articles

Gene expression and angiotropism in primary CNS lymphoma

Free
Clinical Trials & Observations
James L. Rubenstein, Jane Fridlyand, Arthur Shen, Ken Aldape, David Ginzinger, Tracy Batchelor, Patrick Treseler, Mitchel Berger, Michael McDermott, Michael Prados, Jon Karch, Craig Okada, William Hyun, Seema Parikh, Chris Haqq, Marc Shuman
Journal: Blood
Blood (2006) 107 (9): 3716–3723.
https://doi.org/10.1182/blood-2005-03-0897
Published: 2006
Includes: Supplemental data
Journal Articles

Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartment

Free
Clinical Trials & Observations Brief Report
James L. Rubenstein, Dan Combs, Jay Rosenberg, Arthur Levy, Michael McDermott, Lloyd Damon, Robert Ignoffo, Kenneth Aldape, Arthur Shen, Dana Lee, Antonio Grillo-Lopez, Marc A. Shuman
Journal: Blood
Blood (2003) 101 (2): 466–468.
https://doi.org/10.1182/blood-2002-06-1636
Published: 2003